Sequoia Capital China and HighLight Capital have led a RMB550 million ($80 million) pre-IPO funding round for BrightGene Bio-Medical Technology, a Chinese developer of innovative and generic drugs. An investment unit of GF Securities also participated.
The company was established in 2001 and received funding from Lilly Asia Ventures in 2010. AVCJ Research’s records indicate that Suzhou International Development Venture Capital invested the same year,...
Legend Capital sees Mancando's extensive network of brick-and-mortar outlets as the key to bringing greater supply chain efficiency to the Chinese auto parts industry
Advantage Partners has made its first acquisition in Vietnam, buying women’s fashion brand Elise Fashion for an undisclosed amount.
GIC Private has led a RMB850 million ($125.5 million) Series C round for Burning Rock, a Chinese cancer diagnostics start-up that is already working with hospitals on products based on DNA sequencing analysis.
Beacon Venture Capital, the VC unit of Thailand’s Kasikornbank, has led a $6.5 million investment in Jitta, a local financial technology provider and stock analysis platform operator.